A 54-year-old retired Army officer sat down in my office and told me he had been on sildenafil for three years and tadalafil for the year before that. The medications worked at first. They worked less well now. He was taking the maximum dose, timing it carefully, and still failing about half the time. He had also gained 22 pounds in those four years, was sleeping poorly, and could not remember the last time he woke with a morning erection. His prior clinician had offered him an injectable. Nobody had asked him about sleep, body composition, hormone status, or his relationship with his wife.
Erectile dysfunction medications are useful tools. They are not a treatment plan. The PDE5 inhibitors — sildenafil, tadalafil, vardenafil — work by enhancing the vascular response to an existing arousal signal. They do not generate the signal. They do not address the underlying cause of why the signal stopped working. When a patient has been escalating doses, switching molecules, or noticing the medication failing more often, that is the body telling you the underlying problem is progressing while the medication chases the symptom downstream. The conversation that patient needs is not a different pill. It is a real workup.
What is actually going wrong
Erectile function is a final common pathway that depends on intact vascular, hormonal, neurological, and psychological inputs. When function declines in mid-life, it is usually because two or three of those inputs have shifted simultaneously. The clinical mistake I see most often is treating the vascular component with a PDE5 inhibitor while ignoring the others.
Vascular. The penile vasculature is end-organ. It is also the smallest arterial bed that produces a noticeable functional symptom when it starts to fail. Erectile dysfunction is frequently the first warning sign of generalized endothelial dysfunction — the same process that causes coronary artery disease, often three to five years before the cardiac event. From my years in cardiac ICU and the cath lab, I can tell you the men who showed up with their first MI in their fifties almost universally had erectile symptoms preceding it that nobody had treated as a cardiovascular signal. When a 50-year-old man tells me his erections are softening, I am thinking about his lipid profile, his blood pressure pattern, his fasting glucose, and his hs-CRP — not just his testosterone.
Hormonal. Low testosterone is a real and common contributor, but it is rarely the only contributor. Free testosterone matters more than total. SHBG matters. Estradiol — yes, in men — matters because the ratio of testosterone to estradiol affects libido and arousal at the central nervous system level, and aromatization shifts as men gain visceral fat. Thyroid status affects energy and libido. Prolactin should be checked when libido is severely depressed because prolactin-secreting tumors are uncommon but not vanishingly rare and they will not respond to anything else.
Neurological and central. Arousal starts in the brain. Chronic stress, untreated sleep apnea, depression, and certain medications all suppress the central arousal signal. SSRIs are the most common pharmacological cause of new-onset sexual dysfunction I encounter. Beta-blockers, antihistamines, and PPIs each contribute in subsets of patients. The medication review is not optional.
Psychological and relational. This piece gets dismissed both directions — patients who are told it is "all in their head" when it is not, and patients who get every workup but the relational conversation when that is the actual driver. Both errors produce frustrated patients.
Why the morning erection question matters
When I sit down with a man for this conversation, one of the first things I ask is about morning erections — frequency, quality, and trajectory over the past several years. The reason is that the morning erection is a clean physiological signal. It bypasses the psychological and relational layer entirely. A man who is having full, regular morning erections almost certainly has intact vascular and hormonal infrastructure; whatever is going on with performance during sex is more likely psychological or situational. A man who has lost morning erections has lost something physiological — vascular, hormonal, or neurological — and that is the conversation to pursue.
The trajectory matters too. Morning erections that gradually faded over years tell a different story than morning erections that disappeared abruptly six months ago. Gradual loss is usually multifactorial mid-life decline. Abrupt loss prompts me to look hard for a specific event — new medication, new illness, new stressor, new sleep disruption.
How I evaluate someone for this
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
The first sexual-wellness consultation is longer than a standard visit and conducted in a private clinical room. I want detailed history — onset, trajectory, situational versus generalized, medication and supplement list, sleep quality, energy, libido, and the patient's own theory of what is going on. I ask about the relationship without making the conversation about the relationship. I ask about prior treatments and why they are no longer adequate.
Then I order labs. The panel includes total and free testosterone, SHBG, estradiol (sensitive assay), prolactin, full thyroid, fasting insulin, HbA1c, lipid panel, hs-CRP, and a comprehensive metabolic panel. If sleep apnea is suspected from history — snoring, witnessed apnea, daytime fatigue, thick neck, treatment-resistant hypertension — I refer for sleep study. If the cardiovascular picture warrants it, I refer for cardiac workup before initiating any androgen therapy. The comprehensive workup is the foundation everything else gets built on.
The lab review visit is where the actual treatment plan gets built. By that point I know which mechanisms are in play and can have a real conversation about which interventions will move the needle.
What treatment actually looks like
For the man with low free testosterone, men's hormone therapy is foundational. Optimized testosterone improves libido, morning erections, energy, body composition, and the response to PDE5 inhibitors when those are also indicated. The protocol I use is conservative initial dosing with reassessment at six to eight weeks, dose adjustment based on free testosterone and symptom response, and ongoing surveillance of hematocrit, PSA, and estradiol.
For the man with vascular contributors, the cardiovascular workup is the priority and lifestyle intervention is non-negotiable. Resistance training, body composition improvement, lipid management, and blood pressure optimization improve erectile function meaningfully because they improve the underlying endothelial health that erections depend on. This is the part where the cardiac ICU perspective shows up — I take vascular signals seriously because I have seen what happens when they get ignored.
For the man with tissue-quality concerns, regenerative approaches like the P-Shot — a PRP-based intervention available within our ED treatment catalog, with the female counterpart being the O-Shot — can produce changes that medication alone does not, particularly in patients with mild to moderate dysfunction or with Peyronie's disease. The procedure involves a brief blood draw, processing the platelets, applying local anesthetic, and injecting concentrated PRP into the corpora. The procedure itself takes about 30 to 45 minutes and most patients describe it as far less unpleasant than they had anticipated. Tissue response begins at two to four weeks; full effect develops over twelve weeks.
For the man on SSRIs or other pharmacological contributors, the conversation is sometimes about adjusting the medication regimen in coordination with the prescribing clinician — not stopping the antidepressant unilaterally, but exploring alternatives that have less sexual side effect profile.
For the man whose primary issue is relational or anxiety-based, the right referral is to a competent sex therapist, and I have referrals I trust.
What partners need to hear
The conversation with the patient's partner — when she or he comes to the consultation — is one I value. Sexual function is rarely a solo concern. A partner who understands what is being treated, what the timeline looks like, and what realistic expectations are tends to support the process much more effectively than a partner who is left in the dark. I welcome the partner into the conversation when the patient wants that.
Where to go from here
If you are in Columbus, Warner Robins, or anywhere across middle Georgia and you have been on a PDE5 inhibitor that is no longer working as well as it used to, the next step is not a higher dose or a switch to an injectable. The next step is a real workup that asks why the underlying signal has changed. Book a private consultation or schedule directly with the Columbus consultation intake. Bring your medication list, any prior labs, and the timeline of how things have changed. The conversation is private, the workup is comprehensive, and the goal is to actually fix what is wrong rather than mask it for another year.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.